Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04724304 · ClinicalTrials.gov registry record · NA

Myocardial Blood Volume Measurement by Real-Time Myocardial Perfusion Echocardiography Correlates to Myocardial Compressibility by Cardiac Magnetic Resonance Imaging in Healthy Subjects

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
115
Enrollment target

NCT04724304: Completed NA study, sponsored by Mayo Clinic.

NCT04724304 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 115 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04724304, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
115 participants
Enrollment target

Study Summary

This study is being done to find out the normal amount of blood within the heart muscle and the variations in this blood flow between a cardiac MRI and TTE.

Interventions

  • DIAGNOSTIC_TEST Real-Time Myocardial Echocardiography (RTMPE)
  • DIAGNOSTIC_TEST Magnetic resonance image (MRI)

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2021-02-09
Est. Completion 2021-11-11
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04724304

The ClinicalTrials.gov registry entry for NCT04724304 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Real-Time Myocardial Echocardiography (RTMPE) is the first listed.

NCT04724304 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04724304 about?

NCT04724304 is a clinical study titled "Myocardial Blood Volume Measurement by Real-Time Myocardial Perfusion Echocardiography Correlates to Myocardial Compressibility by Cardiac Magnetic Resonance Imaging in Healthy Subjects". This study is being done to find out the normal amount of blood within the heart muscle and the variations in this blood flow between a cardiac MRI and TTE.

What is the current status of trial NCT04724304?

This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2021-02-09. Estimated completion is 2021-11-11.

What interventions are being tested in trial NCT04724304?

The interventions under investigation include: Real-Time Myocardial Echocardiography (RTMPE) (DIAGNOSTIC_TEST), Magnetic resonance image (MRI) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04724304?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.